La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.

Author: Maukasa Kagajin
Country: Solomon Islands
Language: English (Spanish)
Genre: Spiritual
Published (Last): 18 March 2016
Pages: 271
PDF File Size: 17.12 Mb
ePub File Size: 18.31 Mb
ISBN: 338-4-61190-231-1
Downloads: 92596
Price: Free* [*Free Regsitration Required]
Uploader: Shaktibei

ApartadoCP Rituximab in Refractory Autoimmune Hemolytic Anemia in Autoinmune hemolytic anemia during interferon treatment in nine patients with hematological diseases.

Anemia Hemolítica Autoinmune

Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus. Br J Haematol,pp.

Best Pract Res Clin Haematol. SRJ is a prestige metric based on the idea that not all citations are the same. Pediatd Hematol Oncol, 20pp.

American Red Cross; To improve our services and products, we use “cookies” own or third autinmune authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

Previous article Next article. Lupus, 24pp. It was detected the presence of IgG and C3 in Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia.


Blood,pp. Jonasch E, Haluska FG. Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia. Tel, Fax Garratty G, Nance S. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon- a.


In high-grade hemolysis patients, it was found a concentration of autoantibodies between 1 and 3 molecules of IgG per erythrocyte, while in low-grade hemolysis patients it behaved between and 1 molecules. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

Am J Hematol, 84pp. The mechanism of action appears to be linked with the selective B-cell depletion and the aitoinmune of autoantibody levels.

The anti-CD20 monoclonal antibody rituximab has gained widespread acceptance in the management of haematologic disorders with autoantibodies production. The James Blundell Award Lecture The role of rituximab in adults with warm antibody autoimmune hemolytic anaemia.

There was a problem providing the content you requested

Published studies are primarily clinical and epidemiological research but also basic. Lower dose of rituximab in the treatment of elderly hemoliticz hemolytic anemia. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. Rev Cubana Hematol Inmunol Hemoter. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoinmune hemolytic anemia using rituximab.


Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: Estos resultados son similares a los obtenidos en los pacientes con AHAI y en la anemia autoinmune secundaria al tratamiento con alfa metildopa.

Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and in patients who are medically unsuited for espenectomy. Retrospective analysis of 27 cases. Haemolytic anemia to the alpha interferon treatment: Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.

Do we really understand immune red cell destruction? Subscribe to our Newsletter. Rituximab in the treatment of autoimmune haemolytic anaemia.

Key words autoimmune haemolytic anaemia, cold agglutinin disease, rituximab. You can change the settings or obtain more information by clicking here.

The treatment of cold agglutinin disease consists of avoiding cold environments, inmunosuppresive therapy and more recently rituximab.